Others

Voriconazole impurity 1 is an impurity of Voriconazole (HY-76200).

1-Methyl-4-(2,4,6-trimethoxyphenyl)piperidin-3-ol is a drug intermediate for synthesis of various active compounds.

2-Pyrazinecarboxylic acid (Standard) is the analytical standard of 2-Pyrazinecarboxylic acid. This product is intended for research and analytical applications. 2-Pyrazinecarboxylic acid is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

Methyl (3S,6R)-6-methyl-3-piperidinecarboxylate L-tartaric acid salt is a drug intermediate for synthesis of various active compounds.

Apixaban impurity 4 is an impurity of Apixaban (HY-50667).

Ethyl 1,8-dimethyl-4-oxo-4,5-dihydroimidazo[1,2-a]quinoxaline-2-carboxylate is a drug intermediate for synthesis of various active compounds.

Ticagrelor impurity 26 is an impurity of Ticagrelor (HY-10064).

Ticagrelor impurity 19 is an impurity of Ticagrelor (HY-10064).

Ticagrelor impurity 7 is an impurity of Ticagrelor (HY-10064).

Ticagrelor impurity 12 is an impurity of Ticagrelor (HY-10064).

Ticagrelor impurity 22 is an impurity of Ticagrelor (HY-10064).

Ticagrelor impurity 5 is an impurity of Ticagrelor (HY-10064).

Ticagrelor impurity 8 is an impurity of Ticagrelor (HY-10064).

2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile is a drug intermediate for synthesis of various active compounds.

Ibrutinib impurity 2 is an impurity of Ibrutinib.

N-Methylpiperazine-d₁₁ is the deuterium labeled N-Methylpiperazine.

Benzene-1,3,5-tricarboxylic acid-d₃ (Trimesic acid-d₃) is the deuterium labeled Benzene-1,3,5-tricarboxylic acid (HY-78985). Benzene-1,3,5-tricarboxylic acid (Trimesic acid) is a rigid planar small-molecule scaffold and crosslinker. Benzene-1,3,5-tricarboxylic acid induces bicyclic peptides to adopt a planar conformation, so as to maximize surface area and bind to the flat protein surfaces involved in protein-protein interactions. Benzene-1,3,5-tricarboxylic acid forms ionic crosslinks, hydrogen bonds and π-π bonds with chitosan, thereby constructing a hydrogel network. Benzene-1,3,5-tricarboxylic acid endows chitosan hydrogel systems with specific mechanical properties, enabling sustained release of cancer therapeutic drugs including 5-Fluorouracil (HY-90006).

Methyl 9H-xanthene-9-carboxylate (Methyl xanthanoate) is a drug intermediate for synthesis of various active compounds.

tert-Butyl 4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl]methyl]piperazine-1-carboxylate is a drug intermediate for synthesis of various active compounds.

2-Thiazolemethanamine, α-(phenylmethyl)-, (R)- is a drug intermediate for synthesis of various active compounds.